Dapoxetine hydrochloride tablets have been shown to be significantly effective in the treatment of premature ejaculation and poor ejaculatory control in adult male patients aged 18 to 64 years. Current clinical research suggests that the treatment of premature ejaculation with Dapoxetine Hydrochloride Tablets may be related to the fact that Dapoxetine inhibits neuronal reuptake of 5-hydroxytryptamine, which in turn affects the potential difference between the neurotransmitter’s action on the cell’s pre- and postsynaptic receptors. Side effects of dapoxetine hydrochloride tablets are generally transient and manifest as mild headache, nausea and other symptoms. Dapoxetine Hydrochloride Tablets should be used with caution: it is contraindicated in patients who are allergic to the ingredients contained in Dapoxetine Hydrochloride Tablets, it is contraindicated in patients with obvious pathological conditions of the heart, it is contraindicated in patients with moderate and severe hepatic injury, it is contraindicated in patients who are also taking ketoconazole, telithromycin and other strong cytochrome P450 3A4 inhibitors, and the consumption of alcohol during the use of the medication should be avoided. In addition, dapoxetine hydrochloride tablets should not be used concomitantly with monoamine oxidase inhibitors or thioridazine, nor should dapoxetine hydrochloride tablets be taken within 14 days of the use of monoamine oxidase inhibitors or thioridazine. Similarly, monoamine oxidase inhibitors or thioridazine should not be used within 7 days of discontinuing dapoxetine hydrochloride tablets. If dapoxetine hydrochloride tablets are to be taken, patients are advised to follow the instructions of their doctor.